Vivani Medical Launches First Human Trial of GLP-1 Implant for Obesity in Australia
Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™, at two centers in Australia. The trial aims to evaluate…
Axoft Launches Brain Implant Clinical Study with First Bio-Inspired Material for Humans
Axoft, a neurotechnology company, has announced the approval of its first-in-human clinical study, set to begin in early 2025 at The Panama Clinic. The study will explore the usability of Axoft’s innovative soft materials, which mimic the mechanical properties of…
SV Health Investors Elevates A.J. Rossi to Partner on Healthcare Team
SV Health Investors, a prominent healthcare-focused private equity firm, is excited to announce the promotion of A.J. Rossi to Partner on its Growth-Buyout team. In this role, A.J. will continue to lead investments, oversee the SV portfolio, and contribute to…
COTA and Guardant Health Partner to Advance Precision Oncology with AI and Real-World Data
COTA Inc., a leader in real-world data (RWD) and analytics for oncology, has announced a new partnership with precision oncology company Guardant Health Inc. (Nasdaq: GH). This collaboration will provide biopharmaceutical researchers with access to COTA’s research-grade electronic health record…
Palleon Pharmaceuticals and Henlius Collaborate on Glycan Editing for Autoimmune Diseases
Palleon Pharmaceuticals, a leader in glyco-immunology drug development for autoimmune diseases and cancer, has announced a collaboration and licensing agreement with Shanghai Henlius Biotech, Inc. (2696.HK). The agreement focuses on the development and commercialization of Palleon’s novel human sialidase enzyme…
Insitro Secures $25 Million from Bristol Myers Squibb for ALS Target Discovery Milestones
Insitro, a machine learning-driven drug discovery and development company, announced today that it has received $25 million from Bristol Myers Squibb (NYSE: BMY) following the achievement of discovery milestones and the selection of the first novel genetic target for amyotrophic…
Valink Therapeutics Appoints Martin D. Williams as Board Chair, Names Scientific Advisory Board
Valink Therapeutics, a biopharmaceutical company focused on the discovery and development of bispecific antibody-drug conjugates (bsADCs) to treat cancer and other diseases, has announced the appointment of Martin D. Williams as Chair of its Board of Directors. Additionally, the company…
Coya Therapeutics Updates Enrollment in Phase 1 FTD Study
Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotech company, announced that five of eight patients have been enrolled in an investigator-initiated academic study of the LD IL-2 + CTLA4-Ig combination for treating Frontotemporal Dementia (FTD). The study is led by…
ClearNote Health’s Avantect® Test Chosen for World’s Largest Pancreatic Cancer Detection Study
ClearNote Health, a company dedicated to enhancing early cancer detection, has announced a new partnership with researchers at the University of Southampton’s Clinical Trials Unit in the UK. The team will utilize ClearNote’s Avantect® Pancreatic Cancer Test in a groundbreaking…
Noetik Unveils OCTO-VirtualCell and Celleporter: Key Models for Precision Oncology
Noetik, an AI-driven biotech company focused on developing next-generation cancer therapies using self-supervised machine learning and high-throughput spatial data, has announced the release of a technical report on OCTO-VirtualCell (OCTO-vc). This AI model is designed to predict the behavior of…
Alzamend Neuro to Present Non-Clinical Data at 2025 SOT Annual Meeting
Alzamend Neuro, Inc. (Nasdaq: ALZN), a clinical-stage biopharmaceutical company, today announced it will present a poster at the Society of Toxicology (SOT) Annual Meeting and ToxExpo, which will be held from March 16-20, 2025, in Orlando, Florida. The poster will…
ClinChoice Expands 13-Year Medidata Partnership to Enhance Data Management
Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has renewed its long-term partnership with ClinChoice, a contract research organization (CRO). Through this new agreement, ClinChoice will utilize the Medidata Platform to…